Form 4: BioAffinity Technologies Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Timothy P. Zannes, Secretary, EVP, and General Counsel of bioAffinity Technologies, exercised stock options and sold shares to cover the exercise price.
Summary
- On April 4, 2024, Timothy P. Zannes, Secretary, EVP, and General Counsel of bioAffinity Technologies, Inc., exercised stock options to acquire 64,848 shares of common stock at a price of $1.16 per share.
- Following the exercise of the options, Mr. Zannes sold 29,031 shares at $2.58 per share to cover the exercise price of the options.
- After these transactions, Mr. Zannes directly owns 46,124 shares of bioAffinity Technologies common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions related to stock options and share sales, which are a normal part of executive compensation.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/28/2014 | Start date of the vesting schedule for the stock options, vesting in 7 equal monthly installments. |
| 04/04/2024 | Date of the stock option exercise and share sale. |
| 04/24/2024 | Date of the Form 4 filing. |
Keywords
Form 4, BIAF, bioAffinity Technologies, Zannes, Stock Options, Insider Trading, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.